BI Asset Management Fondsmaeglerselskab’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
25,624
-30,563
| -54% | -$2.39M | 0.02% | 360 |
|
|
2025
Q1 | $4.07M | Sell |
56,187
-16,432
| -23% | -$1.19M | 0.05% | 255 |
|
|
2024
Q4 | $5.38M | Buy |
+72,619
| New | +$5.38M | 0.06% | 224 |
|
|
2024
Q3 | – | Sell |
-73,604
| Closed | -$6.8M | – | 634 |
|
|
2024
Q2 | $6.8M | Buy |
73,604
+40,531
| +123% | +$3.74M | 0.11% | 164 |
|
|
2024
Q1 | $3.16M | Sell |
33,073
-162,969
| -83% | -$15.6M | 0.06% | 218 |
|
|
2023
Q4 | $14.9M | Buy |
196,042
+28,792
| +17% | +$2.2M | 0.32% | 83 |
|
|
2023
Q3 | $11.6M | Sell |
167,250
-9,205
| -5% | -$638K | 0.27% | 93 |
|
|
2023
Q2 | $16.6M | Sell |
176,455
-19,560
| -10% | -$1.85M | 0.39% | 69 |
|
|
2023
Q1 | $16.2M | Sell |
196,015
-8,873
| -4% | -$734K | 0.43% | 63 |
|
|
2022
Q4 | $15.3M | Buy |
204,888
+23,423
| +13% | +$1.75M | 0.41% | 71 |
|
|
2022
Q3 | $15M | Sell |
181,465
-2,615
| -1% | -$216K | 0.76% | 36 |
|
|
2022
Q2 | $17.5M | Buy |
184,080
+7,284
| +4% | +$693K | 0.75% | 44 |
|
|
2022
Q1 | $20.8M | Sell |
176,796
-15,051
| -8% | -$1.77M | 0.8% | 42 |
|
|
2021
Q4 | $24.9M | Sell |
191,847
-11,929
| -6% | -$1.55M | 0.92% | 29 |
|
|
2021
Q3 | $23.1M | Sell |
203,776
-1,828
| -0.9% | -$207K | 0.87% | 29 |
|
|
2021
Q2 | $21.3M | Buy |
205,604
+9,291
| +5% | +$962K | 0.82% | 35 |
|
|
2021
Q1 | $16.4M | Buy |
196,313
+123,660
| +170% | +$10.3M | 0.67% | 49 |
|
|
2020
Q4 | $6.63M | Buy |
72,653
+10,646
| +17% | +$971K | 0.29% | 81 |
|
|
2020
Q3 | $4.95M | Buy |
62,007
+13,394
| +28% | +$1.07M | 0.22% | 97 |
|
|
2020
Q2 | $3.36M | Sell |
48,613
-1,820
| -4% | -$126K | 0.17% | 121 |
|
|
2020
Q1 | $3.17M | Buy |
50,433
+17,211
| +52% | +$1.08M | 0.19% | 98 |
|
|
2019
Q4 | $2.58M | Buy |
33,222
+27,519
| +483% | +$2.14M | 0.12% | 158 |
|
|
2019
Q3 | $418K | Sell |
5,703
-708
| -11% | -$51.9K | 0.02% | 292 |
|
|
2019
Q2 | $395K | Buy |
+6,411
| New | +$395K | 0.02% | 171 |
|